A. Erlandson

发表

Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG‐Ia)

H. Freeze, M. Schwartz, G. Matthijs, 2000, Human mutation.

PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families

S. Nilsson, C. Bjursell, J. Wahlström, 2000, Human mutation.

Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations

C. Bjursell, J. Wahlström, T. Martinsson, 2001, Human Genetics.

Aetiology of severe mental retardation and further genetic analysis by high‐resolution microarray in a population‐based series of 6‐ to 17‐year‐old children

M. Kyllerman, A. Erlandson, M. Lundvall, 2012, Acta paediatrica.

MECP2 Abnormality Phenotypes: Clinicopathologic Area With Broad Variability

B. Hagberg, A. Erlandson, 2005, Journal of child neurology.

Deletion of the MGMT gene in familial melanoma

C. Enerbäck, T. Martinsson, A. Erlandson, 2014, Genes, chromosomes & cancer.

Epigenetic mutations in CDKN2A in western Swedish families with hereditary malignant melanoma.

C. Enerbäck, A. Erlandson, Frida Appelqvist, 2008, Molecular medicine reports.

Novel CDKN2A mutations detected in western Swedish families with hereditary malignant melanoma.

C. Enerbäck, A. Wennberg, A. Erlandson, 2007, The Journal of investigative dermatology.

Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients.

L. Samuelsson, M. Kyllerman, B. Hagberg, 2003, Genetic testing.

Outbreaks of Campylobacter enteritis in two extended families: evidence for person-to-person transmission.

M. Blaser, T. Barrett, R. Waldman, 1981, The Journal of pediatrics.

Early Infantile Onset ‘‘Congenital’’ Rett Syndrome Variants: Swedish Experience Through Four Decades and Mutation Analysis

M. Kyllerman, B. Hagberg, A. Erlandson, 2011, Journal of child neurology.

MECP2 mutation screening in Swedish classical Rett syndrome females

B. Hagberg, B. Hallberg, J. Wahlström, 2001, European Child & Adolescent Psychiatry.

Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients.

J. Wahlström, T. Martinsson, B. Kristiansson, 2000, Genetic Testing.